SPIA
SLS icon

Steward Partners Investment Advisory’s SELLAS Life Sciences SLS Stock Holding History

Steward Partners Investment Advisory’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed – – 2536
2018
Q1 		$0 Hold
1
– – ﹤0.01% 2319
2017
Q4 		$0 Hold
1
– – ﹤0.01% 1941
2017
Q3 		$0 Hold
1
– – ﹤0.01% 1752
2017
Q2 		$0 Hold
1
– – ﹤0.01% 1687
2017
Q1 		$0 Buy
+1
New +$1.66K ﹤0.01% 1558
2016
Q4 		– Hold
0
– – – 890

Other funds holding SLS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Steward Partners Investment Advisory's SLS Position: Q2 2018 in Review

Steward Partners Investment Advisory sold out of SELLAS Life Sciences (SLS) in Q2 2018, closing a stake of 1 share.

Steward Partners Investment Advisory first reported a position in SLS in Q1 2017 and held it in 5 quarters. The position peaked at $0 in Q1 2018. 14 funds tracked by Wall St. Rank hold SLS as of Q2 2018.

  • Steward Partners Investment Advisory reported no remaining SELLAS Life Sciences position as of Q2 2018 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1 SELLAS Life Sciences share in Q2 2018.
  • Steward Partners Investment Advisory first reported a position in SELLAS Life Sciences in Q1 2017 and held it in 5 quarters.
  • Steward Partners Investment Advisory's SELLAS Life Sciences position peaked at $0 in Q1 2018.
  • 14 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2018, filed 20 Jul 2018.